IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Lonza Expands Viral-Based Therapeutics Business with New cGMP Unit at Houston

1:53 AM MDT | May 18, 2011 | Natasha Alperowicz

Lonza says it will expand its viral-based therapeutics business with the construction of a new cGMP clean room adjacent to its existing Houston operations. The facility will offer large-scale capacity to support late-stage viral vaccine and gene therapy projects. It will use disposable process systems and be able to support production anf fill/finish operations of up to 2,000 liters. Enhanced, EU compliant, fill and finish capabilities are in high demand from Lonza's pharma and biotech customers, the company says. The expansion will also reduce Lonza's clients'...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa